NORTH ADAMS, Mass. -- The creation of the new Lucian Leape Institute at the National Patient Safety Foundation (NPSF) was announced today at NPSF's annual Patient Safety Congress in Washington, D.C. Dr. Lucian Leape is a physician and adjunct professor of health policy at the Harvard School of Public Health, and is internationally recognized as a founder and leader of the patient safety movement. The National Patient
Safety Foundation's Annual Patient Safety Congress brings together patient safety experts, practitioners, patients and other stakeholders to share new strategies, research, and knowledge focused on improving the safety of the healthcare system.
The Lucian Leape Institute will function as a think tank and define strategic paths and calls to action for the field of patient safety, intended to provide vision and context for the many efforts underway within the healthcare system. Through its roundtables, it will issue reports that will guide the work of the field and challenge the system to address the issues critical to making the system safer.
"The National Patient Safety Foundation has been honored to work with Dr. Leape since our founding, and we are pleased to be able to recognize his leadership in the field through the establishment of this Institute," says Diane C. Pinakiewicz, president of the NPSF. "The work of the Institute will provide important guidance for the many improvement efforts underway in the field."
Source: National Patient Safety Foundation
  Â
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.